Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

PD-1 agonist development progress inventory, which players on the agonist track?
With annual sales of $1.4 billion, the race is on for the first copy of this innovative drug

With annual sales of $1.4 billion, the race is on for the first copy of this innovative drug

2023-06-01

When it comes to HIF-PHI drugs, chronic kidney disease anemia will come to mind without thinking.

J. Med. Chem. | for new protein degradation molecules of KRAS mutations

J. Med. Chem. | for new protein degradation molecules of KRAS mutations

2023-06-01

Novel protein degrading molecule for KRAS Mutation!

Breakthrough and question, Will recombinant Collagen become the next 100 billion track

Breakthrough and question, Will recombinant Collagen become the next 100 billion track

2023-06-01

Despite the skepticism, the effect of recombinant collagen is obvious.

Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab

Indonesian pharmaceutical company Biofarma announces the acquisition of US Pharma Lab

2023-05-29

Recently, Biofarma, an Indonesian pharmaceutical company jointly controlled by Ardian and the Scarpa family, announced a final agreement to acquire 100% equity in CDMO company US Pharma Lab.

PHARMAC SOUTH

PHARMAC SOUTH

2023-05-16

South india's leading Pharmaceutical Exhibition is on its way!

MEDEXPO KENYA 2023

MEDEXPO KENYA 2023

2023-05-16

The increasing demand for medical manufacturing products, equipment, machinery, services and solutions has prompted a surge of representation at Africa's premier medical exhibition, MEDEXPO AFRICA - KENYA 2023.

ACS Med. Chem. Lett. | first not two aromatic amine MEK - PROTAC protein JiangXieJi P6b
Huadong Pharmaceutical oral small molecule GLP-1 United States IND approved

Huadong Pharmaceutical oral small molecule GLP-1 United States IND approved

2023-05-16

China medicine (sz.000963) revealed that its small group glp-1 receptor stimulagent hdm1002 new drug clinical trial (indapplication) was approved by the United States fda for the clinical trial of the I phase of the adult type 2 diabetes.

Xuantai medicine mesalazine enteric-coated tablets listed in the United States

Xuantai medicine mesalazine enteric-coated tablets listed in the United States

2023-05-16

Xuantai Pharmaceutical "Mesalazine enteric-coated Tablets (1.2g)" was approved by the US FDA.

Astellas and Iveric Bio entered into a definitive agreement to acquire the company

Astellas and Iveric Bio entered into a definitive agreement to acquire the company

2023-05-16

Astellas wants to build the kingdom of ophthalmology.

Boanbiodulaglutide injection BA5101 completed phase III clinical trial

Boanbiodulaglutide injection BA5101 completed phase III clinical trial

2023-05-16

All subjects were enrolled in the Phase III clinical trial of Boanbiolatoglytide injection BA5101 in China.

Terchang ®, the world's first closed triple inhalation aerosol, was commercially launched in China
Wei Mou Biology announced the completion of more than 100 million yuan D2 round of financing

Wei Mou Biology announced the completion of more than 100 million yuan D2 round of financing

2023-05-08

Weimu Biology has completed a D2 round of financing of over 100 million yuan, which will be used for the research and development of innovative ophthalmic drugs.

Only 3 drugs have been approved! Frozen life, and $1.16 million worth of drugs
$860 million market size, PDC drug development and market analysis

$860 million market size, PDC drug development and market analysis

2023-05-08

Polypeptide-drugconjugate drugs (PDC) are conjugate drug molecules. PDC (Peptide-DrugConjugate) can be used to conjugate peptides with other therapeutic molecules in a covalent manner to produce new compounds.

Another big license from Jun Shi. How does Tripley widen the sea road?
The most expensive acquisition ever! Is Astellas getting its $5.9 billion worth?
Two AD new drugs on the market, revenue is negative, Bojian how to recover the loss?
23 weight loss drugs approved clinical, Shi Yao, Gan Li, Le Pu...

23 weight loss drugs approved clinical, Shi Yao, Gan Li, Le Pu...

2023-05-04

Analysis report on the pattern of diet drug research in China.

  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message